Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and other Xenobiotics
During half a century, cytochrome P450 in its original uniqueness as an optically "wrong" cytochrome has attracted many investigators, who have contributed to the unveiling of a bewildering multiplicity of biologically important functions of the, by now very large, superfamily of cytochrome P 450 enzymes. With its discovery in 1958 and with the advent of more refined spectroscopic methodologies, through the double wavelength spectrophotometry, the mysterious enzyme system began to reveal its secrets in a swift stream of investigative successes. As one of the most extensively studied enzyme systems worldwide the interest in cytochromes P450 very much reflects its importance in the elimination of drugs and other chemicals from the body and its role in chemical toxicity and in the aetiology of diseases such as cancer. There has been significant progress in research in this area in recent years and current books on this subject are now out of date. This much needed, new, fully up-to-date publication fills this gap and emphasises the new relevant topics that have emerged during the last decade in an easily accessible manner. The enzyme system, cytochromes P450, comprises a number of families/subfamilies, and the focus of the book is to deal with each individually, furnishing information directly relevant to scientists involved in the development of chemicals, in particular in the evaluation of their safety. The book has contributions from internationally respected scientists who are research-active in the relevant areas. The authors have made extensive use of figures and tables so that the reader can access the necessary information without always having to read the text. In addition, a very extensive, user-friendly index is a unique hallmark of the book. Part A of this monograph introduces the reader to the current knowledge of the evolutionary development of cytochrome P450 structure and function. Furthermore, it deals with the role of this enzyme in the formation of reactive intermediates. The shrewd and extensive utilisation of the molecular biology methodology very rapidly led to a vast body of enzymes calling for a classification of the plethora of different cytochromes P450 (the superfamily) into families and subfamilies. This is aptly exemplified by the ten chapters in Part B of this book, dealing with ten subfamilies and two families of cytochrome P450. Part C offers an insight into another aspect of cytochrome P450 research, namely its regulation through receptor-mediated stimuli - as opposed to enzyme induction or inhibition. The final chapter translates the current data on one of several drug metabolising systems into clinical application and highlights the role of cytochromes P450 in the treatment of neoplastic growth. The book deals extensively with each family/subfamily of the cytochromes P450 that contribute to the metabolism of xenobiotics. Essential and invaluable information is provided for the industrial research scientist working with fine chemicals, and especially those in the pharmaceutical industry, dealing with the safety evaluation of chemicals or being involved in the study of their metabolism, pharmacokinetics and toxicological properties. It should also prove of interest to Regulators concerned with the safety evaluation of chemicals, research pharmacologists and toxicologists, and postgraduate students studying drug metabolism and toxicology at an advanced level.
Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and other Xenobiotics, The Royal Society of Chemistry, 2008.
Download citation file:
Digital access
Print format
Table of contents
-
Chapter 1: Cytochrome P450 Structure and Function: An Evolutionary Perspectivep3-45ByDavid F.V. Lewis;David F.V. LewisSchool of Biomedical and Molecular Sciences, University of SurreyGuildfordSurreyGU2 7XHUKSearch for other works by this author on:Yuko ItoYuko ItoDepartment of Bioscience and BioinformaticsKyusku Institute of Technology680-4 KawazuIizuka-CityFukuoka820-8502JapanSearch for other works by this author on:
-
Chapter 2: Generation of Reactive Intermediates by Cytochromes P450p46-94ByHermann M. Bolt;Hermann M. BoltInstitut für Arbeitsphysiologie an der Universität DortmundLeibniz Research Centre for Work Environment and Human FactorsArdeystr. 67D-44139 DortmundGermanySearch for other works by this author on:Peter H. RoosPeter H. RoosInstitut für Arbeitsphysiologie an der Universität DortmundLeibniz Research Centre for Work Environment and Human FactorsArdeystr. 67D-44139 DortmundGermanySearch for other works by this author on:
-
Chapter 3: The CYP1A Subfamilyp97-135ByBhagavatula MoorthyBhagavatula MoorthyDepartment of PediatricsBaylor College of MedicineHoustonTX 77030USASearch for other works by this author on:
-
Chapter 4: The CYP1B Subfamilyp136-149ByMorag C.E. McFadyen;Morag C.E. McFadyenSchool of Pharmacy, Robert Gordon UniversitySchoolhillAberdeenAB10 1FRSearch for other works by this author on:Graeme I. MurrayGraeme I. MurrayDepartment of Pathology, University of AberdeenMedical School BuildingsForesterhillAberdeenAB25 2ZDSearch for other works by this author on:
-
Chapter 5: The CYP2A Subfamilyp150-177ByHannu Raunio;Hannu RaunioDepartment of Pharmacology and ToxicologyBox 162770211 KuopioFinland (HR)Search for other works by this author on:Jukka Hakkola;Jukka HakkolaDepartment of Pharmacology and Toxicology, University of OuluBox 500090014 OuluFinlandSearch for other works by this author on:Olavi PelkonenOlavi PelkonenDepartment of Pharmacology and Toxicology, University of OuluBox 500090014 OuluFinlandSearch for other works by this author on:
-
Chapter 6: The CYP2B Subfamilyp178-199ByLaurent Corcos;Laurent CorcosINSERM U613/EA948, Faculty of Medicine22 avenue Camille Desmoulins29200BRESTFRANCESearch for other works by this author on:François BerthouFrançois BerthouINSERM U613/EA948, Faculty of Medicine22 avenue Camille Desmoulins29200BRESTFRANCESearch for other works by this author on:
-
Chapter 7: The CYP2C Subfamilyp200-240ByStephen S. Ferguson;Stephen S. FergusonCellzDirectDurhamNC 27703Search for other works by this author on:Jonathan P. JacksonJonathan P. JacksonCellzDirectAustinTX 78754Search for other works by this author on:
-
Chapter 8: The CYP2D Subfamilyp241-275ByUlrich M. ZangerUlrich M. ZangerDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and the University of TuebingenAuerbachstr. 112D-70376StuttgartGermanySearch for other works by this author on:
-
Chapter 9: The CYP2E Subfamilyp276-308ByLowell C. Overton;Lowell C. OvertonInstitute of Environmental Health Sciences, Wayne State University2727 Second Avenue, Room 4000Detroit, MI48201-2654Search for other works by this author on:Alice Hudder;Alice HudderInstitute of Environmental Health Sciences, Wayne State University2727 Second Avenue, Room 4000Detroit, MI48201-2654Search for other works by this author on:Raymond F. NovakRaymond F. NovakInstitute of Environmental Health Sciences, Wayne State University2727 Second Avenue, Room 4000Detroit, MI48201-2654Search for other works by this author on:
-
Chapter 10: The CYP2F, CYP2G and CYP2J Subfamiliesp309-353ByQing-Yu Zhang;Qing-Yu ZhangWadsworth Center, New York State Department of Health, and School of Public HealthState University of New York at AlbanyAlbanyNY 12201USASearch for other works by this author on:Xinxin DingXinxin DingWadsworth Center, New York State Department of Health, and School of Public HealthState University of New York at AlbanyAlbanyNY 12201USASearch for other works by this author on:
-
Chapter 11: The CYP3 Familyp354-383ByDavid J. Greenblatt;David J. GreenblattDepartment of Pharmacology and Experimental TherapeuticsTufts University School of Medicine and Tufts-New England Medical CenterBoston MAUSASearch for other works by this author on:Ping He;Ping HeDepartment of Pharmacology and Experimental TherapeuticsTufts University School of Medicine and Tufts-New England Medical CenterBoston MAUSASearch for other works by this author on:Lisa L. von Moltke;Lisa L. von MoltkeDepartment of Pharmacology and Experimental TherapeuticsTufts University School of Medicine and Tufts-New England Medical CenterBoston MAUSASearch for other works by this author on:Michael H. CourtMichael H. CourtDepartment of Pharmacology and Experimental TherapeuticsTufts University School of Medicine and Tufts-New England Medical CenterBoston MAUSASearch for other works by this author on:
-
Chapter 12: The CYP4 Familyp384-414ByAllan E. Rettie;Allan E. RettieDepartments of Medicinal Chemistry and Pharmaceutics, University of WashingtonSeattleWA 98195USASearch for other works by this author on:Edward J. KellyEdward J. KellyDepartments of Medicinal Chemistry and Pharmaceutics, University of WashingtonSeattleWA 98195USASearch for other works by this author on:
-
Chapter 13: Receptor-Mediated Regulation of Cytochromes P450p417-448ByKouichi Yoshinari;Kouichi YoshinariDivision of Drug Metabolism and Molecular ToxicologyGraduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-kuSendaiMiyagi 980-8578JapanSearch for other works by this author on:Eric Tien;Eric TienPharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle ParkNorth Carolina 27709USASearch for other works by this author on:Masahiko Negishi;Masahiko NegishiPharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle ParkNorth Carolina 27709USASearch for other works by this author on:Paavo HonkakoskiPaavo HonkakoskiDepartment of Pharmaceutics, University of KuopioP. O. Box 1627, FIN-70211, Kuopio, Finland andSearch for other works by this author on:
-
Chapter 14: Modulation of Cytochromes P450 by Phytochemicalsp449-479ByMichael MurrayMichael MurrayPharmacogenomics and Drug Development Group, Faculty of Pharmacy, University of SydneyNSW2006AustraliaSearch for other works by this author on:
-
Chapter 15: Cytochromes P450 in Cancer Therapeuticsp480-509ByThomas K.H. ChangThomas K.H. ChangFaculty of Pharmaceutical Sciences, The University of British ColumbiaVancouverBritish ColumbiaV6T 1Z3CanadaSearch for other works by this author on:
Spotlight
Advertisement
Advertisement